TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cronos Australia Ltd. ( (AU:VIT) ) has shared an update.
Vitura Health Limited reported positive business momentum in Q3 FY2025, aligning with its Strategic Reset goals. The company saw successive revenue and EBITDA growth, driven by the integration of Candor Medical and Releaf Group, expansion of its Canview platform, and operational efficiencies. Despite slightly missing its annual revenue growth target, Vitura anticipates meeting its EBITDA margin and OPEX efficiency goals, setting a strong foundation for FY2026.
More about Cronos Australia Ltd.
Vitura Health Limited is a leading digital health platform business in Australia, focusing on traditional and emerging therapies. The company is involved in integrating acquired businesses to enhance revenue and EBITDA, while expanding its Canview platform and maintaining cost control.
Average Trading Volume: 497,298
Technical Sentiment Signal: Sell
Current Market Cap: A$47.68M
For a thorough assessment of VIT stock, go to TipRanks’ Stock Analysis page.